Faculty
Oncology Division
Alphabetical list (active faculty):   
Katrina S. Pedersen

Katrina S. Pedersen, MD, MS

Assistant Professor

Department of Medicine

Oncology Division

Medical Oncology

Clinical Interests

  • Small bowel adenocarcinoma
  • Colorectal cancer
  • Appendiceal cancer
  • Pancreatic cancer
  • Gastrointestinal cancer

Contact

  • 314-362-9115 (office)
  • 314-362-7086 (fax)
  • Division of Oncology
    Mail Stop 8056-0029-11
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110

Peer-reviewed Manuscripts

  • Clinical Complete Response in Patients With Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Nonoperative Management
    Chin RI, Roy A, Pedersen KS, Huang Y, Hunt SR, Glasgow SC, Tan BR, Wise PE, Silviera ML, Smith RK, Suresh R, Badiyan S, Shetty AS, Henke LE, Mutch MG, Kim H
    Int J Radiat Oncol Biol Phys 2021 Oct 12; [Epub ahead of print]
  • Vorolanib (X-82), an Oral Anti-VEGFR/PDGFR/CSF1R Tyrosine Kinase Inhibitor, With Everolimus in Solid Tumors: Results of a Phase I Study
    Pedersen KS, Grierson PM, Picus J, Lockhart AC, Roth BJ, Liu J, Morton A, Chan E, Huffman J, Liang C, Wang-Gillam A, Tan B
    Invest New Drugs 2021 Oct;39(5):1298-1305
  • Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial
    Kim H, Pedersen K, Olsen JR, Mutch MG, Chin RI, Glasgow SC, Wise PE, Silviera ML, Tan BR, Wang-Gillam A, Lim KH, Suresh R, Amin M, Huang Y, Henke LE, Park H, Ciorba MA, Badiyan S, Parikh PJ, Roach MC, Hunt SR
    Clin Colorectal Cancer 2021 Sep;20(3):e185-e193
  • CtDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine
    Pellini B, Pejovic N, Feng W, Earland N, Harris PK, Usmani A, Szymanski JJ, Qaium F, Mudd J, Petty M, Jiang Y, Singh A, Maher CA, Henke LE, Park H, Ciorba MA, Kim H, Mutch MG, Pedersen KS, Tan BR, Hawkins WG, Fields RC, Chaudhuri AA
    JCO Precis Oncol 2021 Feb 12;5
  • Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial
    Jatoi A, Ou FS, Ahn DH, Zemla TJ, Le-Rademacher JG, Boland P, Ciombor KK, Jacobs NL, Pasche B, Cleary JM, McCune JS, Pedersen KS, Barzi A, Chiorean EG, Heying EN, Lenz HJ, Sloan JA, Grothey A, Lacouture ME, Bekaii-Saab T
    Oncologist 2021 Jul;26(7):610-618
  • Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
    Benson A 3rd, Venook A, Al-Hawary M, Arain M, Chen YJ, Ciombor K, Cohen S, Cooper H, Deming D, Farkas L, Garrido-Laguna I, Grem J, Gunn A, Hecht JR, Hoffe S, Hubbard J, Hunt S, Johung K, Kirilcuk N, Krishnamurthi S, Messersmith W, Meyerhardt J, Miller E, Mulcahy M, Nurkin S, Overman M, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber J, Sofocleous C, Stoffel E, Stotsky-Himelfarb E, Willett C, Gregory K, Gurski L
    J Natl Compr Canc Netw 2021 Mar 2;19(3):329-359
  • ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients With Advanced Small-Bowel Adenocarcinoma
    Pedersen KS, Foster NR, Overman MJ, Boland PM, Kim SS, Arrambide KA, Jaszewski BL, Bekaii-Saab T, Graham RP, Welch J, Wilson RH, McWilliams RR
    Clin Cancer Res 2021 Jul 1;27(13):3641-3648
  • NCCN Guidelines Insights: Rectal Cancer, Version 6.2020
    Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Gunn A, Hoffe S, Hubbard J, Hunt S, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Johnson-Chilla A, Gurski LA
    J Natl Compr Canc Netw 2020 Jul;18(7):806-815
  • BL-8040, a CXCR4 Antagonist, in Combination With Pembrolizumab and Chemotherapy for Pancreatic Cancer: The COMBAT Trial
    Bockorny B, Semenisty V, Macarulla T, Borazanci E, Wolpin BM, Stemmer SM, Golan T, Geva R, Borad MJ, Pedersen KS, Park JO, Ramirez RA, Abad DG, Feliu J, Munoz A, Ponz-Sarvise M, Peled A, Lustig TM, Bohana-Kashtan O, Shaw SM, Sorani E, Chaney M, Kadosh S, Vainstein Haras A, Von Hoff DD, Hidalgo M
    Nat Med 2020 Jun;26(6):878-885
  • FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical Trial
    Park H, Jin RU, Wang-Gillam A, Suresh R, Rigden C, Amin M, Tan BR, Pedersen KS, Lim KH, Trikalinos NA, Acharya A, Copsey ML, Navo KA, Morton AE, Gao F, Lockhart AC
    JAMA Oncol 2020 Aug 1;6(8):1231-1240
  • Phase Ib/II Study Combining Tosedostat With Capecitabine in Patients With Advanced Pancreatic Adenocarcinoma
    Grierson P, Teague A, Suresh R, Lim KH, Amin M, Pedersen K, Tan B, Huffman J, Boice N, Du L, Liu J, Lockhart AC, Wang-Gillam A
    J Gastrointest Oncol 2020 Feb;11(1):61-67
  • Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology
    Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen SA, Cooper HS, Deming DA, Garrido-Laguna I, Grem JL, Hoffe SE, Hubbard J, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen KS, Saltz LB, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Johnson-Chilla A, Gregory KM, Gurski LA
    J Natl Compr Canc Netw 2019 Sep 1;17(9):1109-1133
  • Regorafenib Dose-Optimisation in Patients With Refractory Metastatic Colorectal Cancer (ReDOS): A Randomised, Multicentre, Open-Label, Phase 2 Study
    Bekaii-Saab TS, Ou FS, Ahn DH, Boland PM, Ciombor KK, Heying EN, Dockter TJ, Jacobs NL, Pasche BC, Cleary JM, Meyers JP, Desnoyers RJ, McCune JS, Pedersen K, Barzi A, Chiorean EG, Sloan J, Lacouture ME, Lenz HJ, Grothey A
    Lancet Oncol 2019 Aug;20(8):1070-1082
  • CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations
    McWilliams RR, Wieben ED, Chaffee KG, Antwi SO, Raskin L, Olopade OI, Li D, Highsmith WE Jr, Colon-Otero G, Khanna LG, Permuth JB, Olson JE, Frucht H, Genkinger J, Zheng W, Blot WJ, Wu L, Almada LL, Fernandez-Zapico ME, Sicotte H, Pedersen KS, Petersen GM
    Cancer Epidemiol Biomarkers Prev 2018 Nov;27(11):1364-1370
  • Pancreatic Cancer Risk Is Modulated by Inflammatory Potential of Diet and ABO Genotype: A Consortia-Based Evaluation and Replication Study
    Antwi SO, Bamlet WR, Pedersen KS, Chaffee KG, Risch HA, Shivappa N, Steck SE, Anderson KE, Bracci PM, Polesel J, Serraino D, La Vecchia C, Bosetti C, Li D, Oberg AL, Arslan AA, Albanes D, Duell EJ, Huybrechts I, Amundadottir LT, Hoover R, Mannisto S, Chanock SJ, Zheng W, Shu XO, Stepien M, Canzian F, Bueno-de-Mesquita B, Quiros JR, Zeleniuch-Jacquotte A, Bruinsma F, Milne RL, Giles GG, Hebert JR, Stolzenberg-Solomon RZ, Petersen GM
    Carcinogenesis 2018 Jul 30;39(8):1056-1067
  • Pacritinib to Inhibit JAK/STAT Signaling in Refractory Metastatic Colon and Rectal Cancer
    Regenbogen T, Chen L, Trinkaus K, Wang-Gillam A, Tan BR, Amin M, Pedersen KS, Park H, Suresh R, Lim KH, Ratchford E, Brown A, Lockhart AC
    J Gastrointest Oncol 2017 Dec;8(6):985-989
  • Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study
    Pedersen KS, Kim GP, Foster NR, Wang-Gillam A, Erlichman C, McWilliams RR
    Invest New Drugs 2015 Aug;33(4):963-8
  • Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients From Healthy Controls
    Pedersen KS, Bamlet WR, Oberg AL, de Andrade M, Matsumoto ME, Tang H, Thibodeau SN, Petersen GM, Wang L
    PLoS One 2011 Mar 24;6(3):e18223
  • Prevalence of CDKN2A Mutations in Pancreatic Cancer Patients: Implications for Genetic Counseling
    McWilliams RR, Wieben ED, Rabe KG, Pedersen KS, Wu Y, Sicotte H, Petersen GM
    Eur J Hum Genet 2011 Apr;19(4):472-8

Case Reports

  • Improved Subjective Visual Function and Best-Corrected Visual Acuity after External Beam Radiation Therapy of Pancreatic Adenocarcinoma Metastatic to the Choroid
    Fuller S, Henke L, Pedersen K, Rao PK
    Ophthalmology Research & Reports 2021;06:148
  • A 64-Year-Old Man With Progressive Dyspnea and Cough Productive of Copious Amounts of Clear Sputum
    Kloesel B, Domingo Musibay E, Pedersen K, Orfali N, Mattingley J, Vassallo R
    Chest 2012 Jun;141(6):1622-5

Reviews and Chapters

  • Chapter 9: Small Intestine Cancers and Gastrointestinal Stromal Tumors
    Pedersen KS, Trikalinos NA
    In: DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology Review, 5th Edition (Morgensztern D, Govindan R, Devarakonda S, Trikalinos NA, Editors), Wolters Kluwer, Philadelphia, 2022
  • Chapter 10: Pancreas and Hepatobiliary Cancer
    Grierson P, Pedersen KS
    In: DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology Review, 5th Edition (Morgensztern D, Govindan R, Devarakonda S, Trikalinos NA, Editors), Wolters Kluwer, Philadelphia, 2022
  • Diagnosis and Staging of Small Bowel Neoplasms
    Pedersen KS, Overman MJ
    In: UpToDate, Goldberg RM (Ed.), Savarese DMF (Ed.), 2021-present
  • Immunotherapy in Colorectal Cancer
    Mukherji R, Weinberg BA, Pedersen KS
    Hematology/Oncology Clinics [Invited Review, Submitted]
  • Small Bowel Adenocarcinoma: Etiology, Presentation, and Molecular Alterations
    Pedersen KS, Raghav K, Overman MJ
    J Natl Compr Canc Netw 2019 Sep 1;17(9):1135-1141

Non-Refereed Publications